ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Eplerenone Versus Spironolactone in Heart Failure Patients With Glucose Intolerance or Type 2 Diabetes (SNOW)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01586442
Recruitment Status : Active, not recruiting
First Posted : April 26, 2012
Last Update Posted : March 29, 2017
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
Michel White, Montreal Heart Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : March 2015
  Estimated Study Completion Date : March 2018